Recombinant CLEC4C (Litifilimab Biosimilar) antibody

Catalog No. ABIN7597792

The Humanized Chimeric anti-CLEC4C (Litifilimab Biosimilar) antibody has been validated for . It is suitable to detect CLEC4C (Litifilimab Biosimilar) in samples from Human.

Quick Overview for Recombinant CLEC4C (Litifilimab Biosimilar) antibody (ABIN7597792)

Target: CLEC4C (Litifilimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CLEC4C (Litifilimab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CLEC4C (Litifilimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Litifilimab Biosimilar Antibody

Specificity: CLEC4C, C-type lectin superfamily member 7, CLECSF11, C-type lectin domain family 4 member C, Dendritic lectin, CD303, DLEC, HECL, Blood dendritic cell antigen 2, BDCA-2, BDCA2, CLECSF7

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 3.45 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CLEC4C (Litifilimab Biosimilar)

Target: CLEC4C (Litifilimab Biosimilar)

Alternative Name: Litifilimab Biosimilar

Target Type: Biosimilar

Background: CLEC4C, C-type lectin superfamily member 7, CLECSF11, C-type lectin domain family 4 member C, Dendritic lectin, CD303, DLEC, HECL, Blood dendritic cell antigen 2, BDCA-2, BDCA2, CLECSF7

UniProt: Q8WTT0

CAS-No: 2407378-48-5